Polyvascular

Polyvascular is targeting a critical unmet need in pediatric cardiology: durable, minimally invasive pulmonary valves for young children with congenital heart disease (CHD). Its core innovation is a proprietary, medical-grade polymer valve that is easier to manufacture in pediatric sizes, resistant to immune rejection, and designed to accommodate a child's growth. Led by a team with deep medical device and clinical expertise, the company is advancing its lead product toward clinical use, aiming to transform the standard of care and reduce the lifelong burden of open-heart surgeries for pediatric patients.

Proprietary medical-grade polymer platform for designing and manufacturing durable, biocompatible, and size-adaptable transcatheter heart valves, specifically for pediatric applications.

The primary competition consists of surgical biological valves (animal/human tissue) and existing transcatheter valves (e.g., Medtronic Melody, Edwards Sapien), which are not designed or approved for very young children. Polyvascular's main competitive advantage is its dedicated pediatric focus and polymer technology designed specifically for this population.